BeStock  
Stocks › Biotechnology › BBIO

BridgeBio Pharma BBIO

US equityMarket cap rank #1114Biotechnology
$76.03 −$2.15 (-2.75%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $76.03 0.00%
Open$77.85
Prev close$78.18
Day range$75.46 – $78.24
Volume1.48M
Market cap$14.81B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

BBIO at a glance

BBIO last changed hands at $76.03 (down 2.75%). At $14.81B, BridgeBio Pharma is ranked #1114 by size among the 3753 stocks on BeStock.

Over the past 52 weeks it has traded between $62.50 and $93.42, so it sits 18.6% below the top of that range. Holders are ahead 11.6% over twelve months, but down 6.2% across the last three months.

On the chart it holds above both the 50-day ($70.30) and 200-day ($72.76) moving averages; RSI is 55, and the last 30 sessions moved at roughly 38% annualized volatility.

For the quarter ended Sep 2026 it reported $353.17M in revenue, up 192.6% from a year earlier, and a net loss of $60.50M.

16 analysts follow the stock and the average call is "buy". The mean target, $110.00, sits 44.7% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$72.00 / $78.60
Average price today$76.44
Volume1.48MAvg (90d) 2.52M
Turnover$113.03M
Turnover rate0.91%of shares outstanding
Volume ratio0.67vs. recent average pace
Day amplitude3.56%
Market cap$14.81B
Float market cap$12.39B
Shares outstanding163.01M
EPS (TTM)-$3.78
P/B-5.69
Book value / share-$13.37
Net profit (TTM)-$736.35M
Net assets-$2.60B
30-day volatility37.8%annualized
Avg daily range (ATR)3.79%of price, 14 days
Max drawdown (1y)-29.8%-15.7% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

B
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

A
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

C
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

16 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 25.5 · 2026-11-22 08:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability16.0
Momentum57.7
Financial health11.1
Analyst view76.6

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$110.00+44.7% vs. current price
Consensus ratingBuy16 analysts covering
Morningstar fair value$85.00Price is below fair value

Wall Street’s average 12-month target is $110.00, 44.7% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $85.00, so shares trade 10.6% below that estimate. On earnings multiple, it sits in the 1st percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-2.8%
1 week
-2.9%
1 month
+11.6%
3 months
-6.2%
6 months
+10.0%
Year to date
-0.6%
1 year
+11.6%
Day range
$75.46$78.24
52-week range
$62.50$93.42

Technical signals

Full technicals →
Trend readLeaning bullish

5 bullish · 2 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average+0.8%Bullish
Price vs 50-day average+8.2%Bullish
Price vs 200-day average+4.5%Bullish
50-day vs 200-day50d below 200dBearish
RSI (14)54.9Bullish
MACD (12,26,9)2.10Bearish
Bollinger band position55%Bullish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How BBIO ranks on BeStock

Market value#1113 of 3734
Closeness to 52-week high#1367 of 3724
Dollar volume today#932 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

BBIO is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on BBIO.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on BBIO

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

BBIO stock: common questions

What is BBIO's latest share price?

$76.03 is the latest print for BBIO, a move of -2.75% against yesterday's close of $78.18. Today's low and high so far: $75.46 and $78.24.

What is BBIO worth in total?

Equity value comes to $14.81B at the current price. By that measure it is number 1114 of the 3753 names in our coverage.

Where does BBIO sit in its 52-week range?

The year's floor is $62.50 and the ceiling $93.42. Shares are 18.6% away from that ceiling.

Does BBIO send cash back through a dividend?

Our data shows no dividend paid by BridgeBio Pharma over the trailing twelve months.

Do Wall Street analysts like BBIO?

Of 16 analysts, 94% say buy, 6% hold and 0% sell. Price targets average $110.00, with the most cautious at $91.00 and the most optimistic at $156.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on BBIO.

Sign in to join the discussion.

Scroll to Top